H. Martin

发表

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy

A. Zeiher, S. Dimmeler, C. Urbich, 2011, Clinical Research in Cardiology.

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

A. Zeiher, S. Dimmeler, C. Urbich, 2002, Clinical research in cardiology : official journal of the German Cardiac Society.

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.

W. Hofmann, A. Zeiher, S. Dimmeler, 2004, Journal of the American College of Cardiology.

A Pilot Trial to Assess Potential Effects of Selective Intracoronary Bone Marrow–Derived Progenitor Cell Infusion in Patients With Nonischemic Dilated CardiomyopathyCLINICAL PERSPECTIVE

S. Fichtlscherer, A. Zeiher, S. Dimmeler, 2009 .

Enhancement Pilot Trial in Patients With Nonischemic Dilated Cardiomyopathy 1-Year Results of the Transplantation of Progenitor Cells and Functional Regeneration Progenitor Cell Infusion in Patients With Nonischemic Dilated Cardiomyopathy : Final Derived −

S. Fichtlscherer, S. Dimmeler, D. Leistner, 2009 .

A Pilot Trial to Assess Potential Effects of Selective Intracoronary Bone Marrow–Derived ProgenitorCell Infusion in Patients With Nonischemic Dilated Cardiomyopathy: Final 1-Year Results of the Transplantation of Progenitor Cellsand Functional Regeneration Enhancement Pilot Trial in PatientsWith Non

S. Fichtlscherer, A. Zeiher, S. Dimmeler, 2009, Circulation. Heart failure.

Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy:

W. Hofmann, A. Zeiher, S. Dimmeler, 2006, Clinical Research in Cardiology.

Zeiher Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy : Intracoronary Doppler substudy of the TOPCARE-AMI trial

W. Hofmann, A. Zeiher, S. Dimmeler, 2022 .

Effects of Granulocyte Colony Stimulating Factor on Functional Activities of Endothelial Progenitor Cells in Patients With Chronic Ischemic Heart Disease

C. Heeschen, A. Zeiher, S. Dimmeler, 2006 .

Intracoronary infusion of progenitor cells is not associated with aggravated restenosis development or atherosclerotic disease progression in patients with acute myocardial infarction.

A. Zeiher, S. Dimmeler, D. Walter, 2006, European heart journal.

Derived From Patients With Chronic Ischemic Heart Disease Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear

C. Heeschen, A. Zeiher, S. Dimmeler, 2004 .

Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart Disease

C. Heeschen, A. Zeiher, S. Dimmeler, 2004 .

Telomere Gap Between Granulocytes and Lymphocytes Is a Determinant for Hematopoetic Progenitor Cell Impairment in Patients With Previous Myocardial Infarction

K. Dietz, A. Zeiher, S. Dimmeler, 2008, Arteriosclerosis, thrombosis, and vascular biology.

G-CSF Stimulation and Coronary Reinfusion of Mobilized Circulating Mononuclear Proangiogenic Cells in Patients with Chronic Ischemic Heart Disease: Five-Year Results of the TOPCARE-G-CSF Trial

A. Zeiher, S. Dimmeler, D. Leistner, 2012, Cell transplantation.

Gradient separation of granulocytic progenitor cells (CFUc) from human blood mononuclear leukocytes.

H. Martin, T. Fliedner, M. Neumann, 1985, Experimental hematology.

ransplantation of Progenitor Cells nd Regeneration Enhancement n Acute Myocardial Infarction

A. Zeiher, S. Dimmeler, T. Vogl, 2004 .

Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease

S. Fichtlscherer, A. Zeiher, S. Dimmeler, 2001, Circulation research.

Purification of haemopoietic progenitor cells from patients with chronic granulocytic leukaemia using Percoll density gradients and elutriation

E. Matutes, J. Goldman, H. Martin, 1986, British journal of haematology.

Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.

C. Heeschen, S. Fichtlscherer, A. Zeiher, 2003, Blood.

Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart Disease

Stefanie Dimmeler, C. Heeschen, A. Zeiher, 2004, Circulation.

Transcoronary transplantation of progenitor cells after myocardial infarction.

A. Zeiher, S. Dimmeler, U. Fischer-Rasokat, 2006, The New England journal of medicine.

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.

A M Zeiher, M. Tiemann, S. Fichtlscherer, 2001, The Journal of clinical investigation.

Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy

C. Heeschen, R. Brandes, A. Zeiher, 2006, Proceedings of the National Academy of Sciences.

Infarct Remodeling After Intracoronary Progenitor Cell Treatment in Patients With Acute Myocardial Infarction (TOPCARE-AMI): Mechanistic Insights From Serial Contrast-Enhanced Magnetic Resonance Imaging

A. Zeiher, S. Dimmeler, T. Vogl, 2003, Circulation.

Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease

S. Fichtlscherer, A. Zeiher, S. Dimmeler, 2001, Circulation.

Coronary Artery Disease Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable

S. Fichtlscherer, A. Zeiher, S. Dimmeler, 2001 .

Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease

S. Fichtlscherer, A. Zeiher, S. Dimmeler, 2001, Circulation.